Toloria DuVall

Toloria DuVall supports the Army Medical Resources Acquisition Activity under the Defense Health Agency, managing the procurement of advanced biomedical research and life sciences capabilities critical to military medical readiness. Responsible for executing complex acquisitions in support of cutting-edge diagnostic, analytical, and clinical technologies, DuVall ensures alignment with the agency’s strategic imperative to sustain high-performance laboratory infrastructure and accelerate biomedical innovation. Their work centers on securing specialized research tools, automated instrumentation, and translational science platforms that enhance the operational health of U.S. Army personnel, with a focus on end-to-end contract lifecycle management from requirement validation through award and performance oversight. DuVall maintains consistent working relationships with a select group of high-capability contractors, including CHENEGA Professional & Technical Services LLC, SNA International LLC, MABEAL GmbH, Canon Medical Informatics Inc., and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. These partnerships reflect a preference for established entities with proven expertise in biotechnology R&D, medical informatics, and specialized laboratory services. The working relationships are characterized by long-term engagement, technical collaboration, and a focus on mission-critical deliverables rather than transactional procurement. DuVall’s procurement activity is exclusively conducted under full and open competition, with no set-asides designated for 8(a), HUBZone, SDVOSB, or other socioeconomic programs. This reflects a mission-driven prioritization of technical capability and operational readiness over socioeconomic preferences, ensuring that acquisitions are awarded based on the highest technical merit and mission alignment. The agency’s procurement portfolio is entirely focused on NAICS 541714—Research and Development in Biotechnology (except Nanobiotechnology)—encompassing contract actions for molecular diagnostics, proteomic and genomic analysis systems, automated lab workflows, and translational research platforms. DuVall’s expertise lies in acquiring complex, high-value scientific instruments and R&D services that bridge laboratory innovation with frontline military medical applications.